Vivanza Biosciences
₹4.13
+0.1 (2.48%)
05 November, 2024 03:06 BSE: 530057
NSE: VIVANZAISIN: INE984E01035
Start SIP in Vivanza Biosciences
Start SIPVivanza Biosciences Performance
Day Range
52 Week Range
Vivanza Biosciences Technicals
EMA & SMA
Current Price
₹4.13
+0.1 (2.48%)
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 5
- 20 Day
- ₹3.84
- 50 Day
- ₹4.01
- 100 Day
- ₹4.62
- 200 Day
- ₹5.99
- 20 Day
- ₹3.83
- 50 Day
- ₹3.91
- 100 Day
- ₹4.42
- 200 Day
- ₹6.00
Vivanza Biosciences Resistance and Support
PIVOT
₹4.15
| Resistance | |
|---|---|
| First Resistance | 4.20 |
| Second Resistance | 4.28 |
| Third Resistance | 4.33 |
| RSI | 63.36 |
| MFI | 61.28 |
| MACD Single Line | -0.06 |
| MACD | 0.00 |
| Support | |
|---|---|
| First Support | 4.07 |
| Second Support | 4.02 |
| Third Supoort | 3.94 |
Vivanza Biosciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 149,948 | 8,392,590 | 55.97 |
| Week | 406,047 | 38,440,488 | 94.67 |
| 1 Month | 354,137 | 33,430,573 | 94.4 |
| 6 Month | 177,359 | 17,405,966 | 98.14 |
Vivanza Biosciences Result Highlights
Vivanza Biosciences Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Vivanza Biosciences Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-10-17 | Quarterly Results | |
| 2024-08-08 | Quarterly Results | |
| 2024-07-05 | Others | Inter alia, 1) To consider and approve the Director's Report and Secretarial Audit Report along with annexure for the F.Y. 2023-24; split from Rs. 10/- to Re. 1/-. |
| 2024-04-30 | Audited Results | |
| 2024-02-06 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2023-03-24 | Split | Rs.0.00 split from Rs. 10/- to Re. 1/-. |